NASDAQ:PASG

Passage Bio News Headlines

$15.88
-1.32 (-7.67 %)
(As of 04/16/2021 04:00 PM ET)
Add
Compare
Today's Range
$15.55
Now: $15.88
$17.51
50-Day Range
$15.76
MA: $18.40
$21.36
52-Week Range
$12.10
Now: $15.88
$38.23
Volume311,114 shs
Average Volume451,004 shs
Market Capitalization$854.84 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Passage Bio (NASDAQ PASG) News Headlines Today

SourceHeadline
Passage Bio (NASDAQ:PASG)  Shares Down 4.8% Passage Bio (NASDAQ:PASG) Shares Down 4.8%
americanbankingnews.com - April 8 at 2:14 PM
Passage Bio, Inc. (NASDAQ:PASG) Receives Average Rating of "Buy" from BrokeragesPassage Bio, Inc. (NASDAQ:PASG) Receives Average Rating of "Buy" from Brokerages
americanbankingnews.com - April 8 at 5:22 AM
Passage Bio (NASDAQ:PASG) Trading Up 3.7%Passage Bio (NASDAQ:PASG) Trading Up 3.7%
americanbankingnews.com - April 7 at 12:30 PM
Passage Bio Receives European Commission Orphan Designation for PBKR03 for Treatment of Krabbe DiseasePassage Bio Receives European Commission Orphan Designation for PBKR03 for Treatment of Krabbe Disease
finance.yahoo.com - April 5 at 8:31 AM
Amgen (NASDAQ:AMGN) & Passage Bio (NASDAQ:PASG) Financial ContrastAmgen (NASDAQ:AMGN) & Passage Bio (NASDAQ:PASG) Financial Contrast
americanbankingnews.com - April 1 at 8:16 PM
Passage Bio Announces First Patient Dosed in Imagine-1 Study of PBGM01 Gene Therapy for Infantile GM1 GangliosidosisPassage Bio Announces First Patient Dosed in Imagine-1 Study of PBGM01 Gene Therapy for Infantile GM1 Gangliosidosis
finance.yahoo.com - April 1 at 10:00 AM
Moving Average Crossover Alert: Passage Bio (PASG)Moving Average Crossover Alert: Passage Bio (PASG)
finance.yahoo.com - April 1 at 10:00 AM
Passage Bio to Participate in Upcoming April Investor ConferencesPassage Bio to Participate in Upcoming April Investor Conferences
finance.yahoo.com - March 25 at 8:36 AM
Passage Bio Appoints Eliseo O. Salinas, M.D., MSc, as Chief Research & Development OfficerPassage Bio Appoints Eliseo O. Salinas, M.D., MSc, as Chief Research & Development Officer
finance.yahoo.com - March 22 at 9:10 AM
U.S. Food and Drug Administration Grants Fast Track Designation to Three Passage Bio Gene Therapy Candidates Targeting Rare CNS DisordersU.S. Food and Drug Administration Grants Fast Track Designation to Three Passage Bio Gene Therapy Candidates Targeting Rare CNS Disorders
finance.yahoo.com - March 8 at 7:20 AM
Passage Bio Inc to Host Earnings CallPassage Bio Inc to Host Earnings Call
finance.yahoo.com - March 3 at 8:18 AM
Passage Bio Reports Fourth Quarter and Full-Year 2020 Financial Results and Recent Business HighlightsPassage Bio Reports Fourth Quarter and Full-Year 2020 Financial Results and Recent Business Highlights
finance.yahoo.com - March 3 at 8:18 AM
Passage Bio to Participate in Upcoming March Investor ConferencesPassage Bio to Participate in Upcoming March Investor Conferences
finance.yahoo.com - March 2 at 7:39 PM
Passage Bio, Inc. Rings the Nasdaq Stock Market Closing BellPassage Bio, Inc. Rings the Nasdaq Stock Market Closing Bell
nasdaq.com - March 1 at 11:29 PM
Passage Bio, Inc. Rings the Closing BellPassage Bio, Inc. Rings the Closing Bell
nasdaq.com - March 1 at 6:29 PM
Passage Bio to Report Fourth Quarter and Full-Year 2020 Financial Results on March 3, 2021Passage Bio to Report Fourth Quarter and Full-Year 2020 Financial Results on March 3, 2021
finance.yahoo.com - February 24 at 7:15 AM
FDA Clears IND Application for Passage Bio’s Gene Therapy Candidate PBKR03 for Treatment of Patients with Early Infantile Krabbe Disease, A Rare Pediatric Disorder with No Approved Disease-Modifying Treatment OptionsFDA Clears IND Application for Passage Bio’s Gene Therapy Candidate PBKR03 for Treatment of Patients with Early Infantile Krabbe Disease, A Rare Pediatric Disorder with No Approved Disease-Modifying Treatment Options
finance.yahoo.com - February 8 at 8:33 AM
Why Guggenheim Is Bullish On Passage BioWhy Guggenheim Is Bullish On Passage Bio
markets.businessinsider.com - February 4 at 1:10 PM
Benzingas Top Ratings Upgrades, Downgrades For February 4, 2021Benzinga's Top Ratings Upgrades, Downgrades For February 4, 2021
finance.yahoo.com - February 4 at 1:10 PM
What Type Of Shareholders Make Up Passage Bio, Inc.s (NASDAQ:PASG) Share Registry?What Type Of Shareholders Make Up Passage Bio, Inc.'s (NASDAQ:PASG) Share Registry?
finance.yahoo.com - January 28 at 9:35 AM
Passage Bio Receives FDA Clearance of IND Application for PBFT02 Gene Therapy Candidate for Treatment of Patients with Frontotemporal Dementia with Granulin MutationsPassage Bio Receives FDA Clearance of IND Application for PBFT02 Gene Therapy Candidate for Treatment of Patients with Frontotemporal Dementia with Granulin Mutations
finance.yahoo.com - January 28 at 9:35 AM
Philadelphia-area life sciences companies set to raise more than $600M in JanuaryPhiladelphia-area life sciences companies set to raise more than $600M in January
bizjournals.com - January 22 at 2:53 PM
Heres Why Shares of Passage Bio Dropped TodayHere's Why Shares of Passage Bio Dropped Today
finance.yahoo.com - January 22 at 2:53 PM
Passage Bio Announces Pricing of Public OfferingPassage Bio Announces Pricing of Public Offering
finance.yahoo.com - January 21 at 11:29 PM
Passage Bio to Host First of a Series of 2021 Virtual R&D Events on January 25Passage Bio to Host First of a Series of 2021 Virtual R&D Events on January 25
finance.yahoo.com - January 19 at 5:35 PM
Passage Bio Announces Launch of Proposed Public OfferingPassage Bio Announces Launch of Proposed Public Offering
finance.yahoo.com - January 19 at 5:35 PM
NVTA Jan 2023 70.000 putNVTA Jan 2023 70.000 put
in.finance.yahoo.com - January 7 at 12:56 AM
Passage Bio to Present at the 39th Annual J.P. Morgan Healthcare ConferencePassage Bio to Present at the 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 4 at 7:10 PM
NVTA Jan 2022 5.000 putNVTA Jan 2022 5.000 put
in.finance.yahoo.com - January 1 at 11:52 PM
2020 in Review: Philadelphia-area drug developers dazzle Wall Street in big year for IPOs2020 in Review: Philadelphia-area drug developers dazzle Wall Street in big year for IPOs
bizjournals.com - December 23 at 2:06 PM
Philadelphia gene therapy firm Passage Bio signs lease deal for lab space in New JerseyPhiladelphia gene therapy firm Passage Bio signs lease deal for lab space in New Jersey
bizjournals.com - December 17 at 3:04 PM
Passage Bio Announces Gene Therapy Manufacturing Research and Development SitePassage Bio Announces Gene Therapy Manufacturing Research and Development Site
finance.yahoo.com - December 16 at 9:25 AM
Is PASG A Good Stock To Buy Now?Is PASG A Good Stock To Buy Now?
finance.yahoo.com - December 15 at 11:59 PM
Passage Bio Teams with Catalent to Start CGMP Manufacturing for Lead Gene Therapy ProductsPassage Bio Teams with Catalent to Start CGMP Manufacturing for Lead Gene Therapy Products
finance.yahoo.com - December 7 at 7:32 AM
Passage Bio (NASDAQ:PASG) Is In A Good Position To Deliver On Growth PlansPassage Bio (NASDAQ:PASG) Is In A Good Position To Deliver On Growth Plans
finance.yahoo.com - November 24 at 2:03 PM
Passage Bio to Present at Piper Sandler 32nd Annual Healthcare ConferencePassage Bio to Present at Piper Sandler 32nd Annual Healthcare Conference
finance.yahoo.com - November 23 at 6:00 PM
Passage Bio Highlights University of Pennsylvanias Gene Therapy Programs Newly Published Research to Prevent Toxicity Associated with Gene TherapyPassage Bio Highlights University of Pennsylvania's Gene Therapy Program's Newly Published Research to Prevent Toxicity Associated with Gene Therapy
benzinga.com - November 11 at 5:49 PM
Passage Bio Highlights University of Pennsylvania’s Gene Therapy Program’s Newly Published Research to Prevent Toxicity Associated with Gene TherapyPassage Bio Highlights University of Pennsylvania’s Gene Therapy Program’s Newly Published Research to Prevent Toxicity Associated with Gene Therapy
finance.yahoo.com - November 11 at 5:49 PM
Passage Bio to Participate in Upcoming November Investor ConferencesPassage Bio to Participate in Upcoming November Investor Conferences
finance.yahoo.com - November 11 at 7:46 AM
Passage Bio and Invitae Announce Collaboration to Facilitate Genetic Testing to Support Early Diagnosis and Greater Awareness of Clinical Trials for Patients with GM1Passage Bio and Invitae Announce Collaboration to Facilitate Genetic Testing to Support Early Diagnosis and Greater Awareness of Clinical Trials for Patients with GM1
finance.yahoo.com - November 9 at 8:05 AM
Passage Bio to Report Third Quarter 2020 Financial Results on November 10, 2020Passage Bio to Report Third Quarter 2020 Financial Results on November 10, 2020
finance.yahoo.com - November 4 at 9:59 AM
FDA grants two key designations to Passage Bios experimental Krabbe disease therapyFDA grants two key designations to Passage Bio's experimental Krabbe disease therapy
bizjournals.com - October 28 at 5:25 PM
Passage Bio’s PBKR03 nabs Orphan drug tag and accelerated review status for Krabbe diseasePassage Bio’s PBKR03 nabs Orphan drug tag and accelerated review status for Krabbe disease
seekingalpha.com - October 28 at 7:23 AM
Passage Bio’s PBKR03 Receives Orphan Drug and Rare Pediatric Disease Designations from FDA for Treatment of Krabbe DiseasePassage Bio’s PBKR03 Receives Orphan Drug and Rare Pediatric Disease Designations from FDA for Treatment of Krabbe Disease
finance.yahoo.com - October 28 at 7:23 AM
Passage Bios lead gene therapy an Orphan Drug in Europe for rare nerve cell diseasePassage Bio's lead gene therapy an Orphan Drug in Europe for rare nerve cell disease
seekingalpha.com - October 26 at 12:49 PM
Passage Bio’s PBGM01 Receives Orphan Drug Designation from EMA for Treatment of GM1 GangliosidosisPassage Bio’s PBGM01 Receives Orphan Drug Designation from EMA for Treatment of GM1 Gangliosidosis
finance.yahoo.com - October 26 at 7:48 AM
Passage Bio (PASG) Looks Good: Stock Adds 5.4% in SessionPassage Bio (PASG) Looks Good: Stock Adds 5.4% in Session
nasdaq.com - October 14 at 2:12 PM
Passage Bios PBGM01 shows encouraging pre-clinical benefits in murine model of GM1 gangliosidosisPassage Bio's PBGM01 shows encouraging pre-clinical benefits in murine model of GM1 gangliosidosis
seekingalpha.com - October 14 at 9:12 AM
PASG.OQ - Passage Bio Inc Profile | ReutersPASG.OQ - Passage Bio Inc Profile | Reuters
reuters.com - October 3 at 2:28 PM
Passage Bio to Participate in Citi’s 15th Annual BioPharma Virtual ConferencePassage Bio to Participate in Citi’s 15th Annual BioPharma Virtual Conference
finance.yahoo.com - September 3 at 8:09 AM
This page was last updated on 4/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.